Overview
Matthew Karr is an Internal Medicine provider in San Francisco, California. His top areas of expertise are Smoldering Multiple Myeloma and Febrile Neutropenia.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
505 Parnassus Ave, San Francisco, CA 94143
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Periscope Group
Michael Albert is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Albert is highly rated in 28 conditions, according to our data. His top areas of expertise are Nijmegen Breakage Syndrome, Wiskott-Aldrich Syndrome, Hyper IgE Syndrome, Splenectomy, and Spinal Fusion.
University Of California San Francisco
Dr. Michael Matthay is a critical care specialist. He serves as UCSF's associate director of critical care medicine. With funding from the National Institutes of Health, Matthay's research focuses on finding new ways to treat acute respiratory failure in critically ill patients, particularly those with sepsis (a condition in which the body has a potentially life-threating response to infection). His research has contributed to several major therapeutic advances over the past 20 years. Matthay earned his medical degree from the University of Pennsylvania's Perelman School of Medicine. He completed a residency in internal medicine at the University of Colorado Denver, where he also completed a fellowship in cardiovascular-pulmonary medicine. He completed a fellowship in pulmonary disease at UCSF and a cardiology fellowship at the UCSF Cardiovascular Research Institute. Matthay is passionate about medical education, and spends considerable time mentoring physicians and young faculty members to help them develop their careers in both patient care and academic medicine. In 2013, he received the UCSF Lifetime Achievement in Mentoring Award, and in 2014, the American Thoracic Society awarded him the Trudeau Medal, given for lifelong contributions to research, teaching or patient care. Matthay is a member of the American Thoracic Society and Association of American Physicians. In his free time, he enjoys open-water swimming as a member of the San Francisco Dolphin Club, outdoor activities at Point Reyes National Seashore and playing baseball at the Boston Red Sox Fantasy Camp. Dr. Matthay is highly rated in 11 conditions, according to our data. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Pneumonia, COVID-19, Lung Transplant, and Vagotomy.
Liver Tumor Clinic
Marion Peters is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Peters is highly rated in 15 conditions, according to our data. Her top areas of expertise are Hepatitis, Hepatitis C, Hepatitis B, Non-Alcoholic Fatty Liver Disease, and Liver Transplant.
Frequently Asked Questions about Dr. Matthew Karr
How do I make an appointment with Dr. Matthew Karr?
You can book an appointment with Dr. Matthew Karr by calling their office at 415-476-4029. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Matthew Karr a top-rated expert for Smoldering Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew Karr is classified as an Experienced expert for Smoldering Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Matthew Karr specialize in?
While Dr. Matthew Karr is a Internal Medicine, they have specific expertise in Smoldering Multiple Myeloma, Febrile Neutropenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Matthew Karr participate in research or clinical trials?
Yes. Dr. Matthew Karr has published 2 articles and abstracts on conditions like Smoldering Multiple Myeloma. You can view a list of Dr. Matthew Karr's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Matthew Karr accept my insurance?
Dr. Matthew Karr accepts most major insurance plans, including Anthem BCBS and Blue Shield of California. We recommend calling the office directly at 415-476-4029 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Febrile NeutropeniaDr. Karr isExperienced. Learn about Febrile Neutropenia.
- Smoldering Multiple MyelomaDr. Karr isExperienced. Learn about Smoldering Multiple Myeloma.